Symptomatic vs. Asymptomatic Carotid Endarterectomy

Slides:



Advertisements
Similar presentations
Governance of a Stroke Thrombolysis Service
Advertisements

ECST-2: An update Martin M Brown Professor of Stroke Medicine UCL Institute of Neurology Queen Square, London ACST-2 Collaborators.
Learn neurology “stroke by stroke.” C.M.Fisher. History Wepfer was the first in 1658, to recognize the significance of carotid obstruction and its relationship.
Eric Hager, MD Assistant Professor of Surgery Division of Vascular surgery University of Pittsburgh Medical Center 1.
St Luke’s- Hospital Carotid Intervention Position Statement1.
Is Carotid Stenting an Option for Treatment of Carotid Stenosis? Joint Hospital Surgical Grand Round WH WONG Queen Mary Hospital.
Indications for CAS vs Surgical_Medical Marianne Brodmann Division of Angiology Graz.
? This project was funded by the National Institute for Health Research Health Technology Assessment (NIHR HTA) Programme (project number 06/301/233) and.
Author: Pop Raluca Alexandra Coordinator: Univ.Asist. Dr. Muresan Adrian.
Stenting and Angioplasty with Protection in Patients at High-Risk for Endarterectomy Presented by Jay Yadav, MD on behalf of the SAPPHIRE Investigators.
Critical Appraisal of an Article on Therapy. Why critical appraisal? Why therapy?
Lessons from TAVR Randomized Trials and Registries E Murat Tuzcu, MD Professor of Medicine Cleveland Clinic Financial disclosures: None PARTNER Executive.
Journal Club Ani Balmanoukian and Peter Benjamin November 9, 2006 Journal Club Ani Balmanoukian and Peter Benjamin November 9, 2006.
Carotid Endarterectomy versus Stenting: Where do we stand today? Vascular Conference March 23, 2010.
Endovascular Management of Intracranial and Extracranial Atherosclerosis Rishi Gupta, MD Associate Professor of Neurology, Neurosurgery, and Radiology.
Hind Alnajashi. C AROTID ARTERY ANATOMY Common carotid artery Aortic arch Internal carotid MCA ACA Ophthalmic artery. Cervical segment Petrous segment.
Rashad MAHMUDOV Central Hospital of Oilworkers, Baku-Azerbaijan
Funding: Health Foundation, ESVS The implications of the GALA trial: General Anaesthesia vs Local (regional) Anaesthesia for Carotid Surgery 3 rd UK Stroke.
Using stroke scales to assess the patient – Rankin and NIHSS
Vascular Trials UPDATE. Infra-renal AAA UK Small Aneurysm Trial (Lancet 98) –Method n1090 Surveillance 4-5.5cm V’s Open repair –Result No diff in all.
Professor Jean – Baptiste Ricco Hospital Jean Bernard, Poitiers, France Hospital Jean Bernard, Poitiers, France.
Carotid Artery Stenosis: Stenting vs. Endarterectomy Városmajor Study. L. Entz,, E.Dósa, K. Hüttl. Department of Cardiovascular Surgery, Semmelweis University,
Endarterectomy versus Stenting in Patients with Symptomatic Severe Carotid Stenosis Dr. Quan, Dr. Mirhashemi, Dr. Chiang N Engl J Med 2006; 355:
Epidemiology in HK  Stroke is major cause of morbidity and mortality around the world  4th cause of mortality in HK resulting in >3000 deaths every.
VASCULAR ANAESTHESIA TIPS AND TRICKS OR HOW NOT TO GET CAUGHT! DR KEVIN M SADLER STH.
AIRE: Acute Infarction Ramipril Efficacy study Purpose To determine whether the ACE inhibitor ramipril reduces mortality in patients with evidence of heart.
Veterans Affairs Cooperative Asymptomatic Study ; published 1993 in NEJM. Randomized 444 asymptomatic men with 50-99% stenosis CEA/ASA or ASA.
Patch, Bypass or Stent for Restenosis following Carotid Endarterectomy Th. Hölzenbein 1, M. Aspalter 1, K. Linni 1, N. Mader 1, W. Hitzl 2, A. Ugurluoglu.
Atherosclerotic Disease of the Carotid Artery Atherosclerosis is a degenerative disease of the arteries resulting in plaques consisting of necrotic cells,
J M CARDON PRIVATE HOSPITAL FRANCISCAINES NIMES FRANCE.
INTRA-ARTERIAL IMMUNOSELECTED CD34+ STEM CELLS FOR ACUTE ISCHEMIC STROKE BANERJEE, S., ET. AL. STEM CELLS TRANSLATIONAL MEDICINE Presentation by.
Funding: Health Foundation, ESVS The GALA Trial General versus Local Anaesthesia for Carotid Endarterectomy Michael J Gough on behalf of the GALA Trial.
Hospital mortality rate on average is 20% higher in non-trial hospitals. 60% of hospitals perform fewer than 17 CEA per year. 88% of surgeons perform at.
Applying CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage 2) in a Pre- Hospital Wilderness Context Paul B. Jones PGY1.
Thrombolysis for acute ischaemic stroke Clinical
© 2005 American Academy of NeurologyFebruary 25, 2004 Assessment: Carotid Endarterectomy― An Evidence-Based Review Report of the Therapeutics and Technology.
Chronic pelvic pain Journal Club 17 th June 2011 Dr Claire Hoxley (GPST1) Dr Harpreet Rayar (GPST2)
© 2005 American Academy of NeurologyFebruary 25, 2004 Assessment: Carotid Endarterectomy― An Evidence-Based Review Report of the Therapeutics and Technology.
Carotid Disease – Stent vs Surgery vs Medical Therapy? Mehdi H. Shishehbor, DO, MPH, PhD Director, Endovascular Services Interventional Cardiology & Vascular.
Sanaz Sakiani, MD Endocrinology Fellow Journal Club
CAROTID ARTERY ENDARTHERECTOMY &INTERVENTION
10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial 颈动脉内膜切除术无症状狭窄 多中心随机试验.
Faramarz Amiri MD IUMS.  Severe carotid disease (defined as >80%) 8–12%  Severe carotid disease (>70%) in those with three vessel or left main coronary.
Dr. Quan, Dr. Mirhashemi, Dr. Chiang
EBM R1張舜凱.
(p for noninferiority = 0.01)
UPDATE IN CAROTID ARTERY STENTING & STROKE MANAGEMENT
John P. A. Ioannidis (age 50) Stanford School of Medicine, Athens Graduate, former chairman Department of Hygiene and Epidemiology, University of Ioannina.
Hemicraniectomy in Older Patients with Extensive Middle-Cerebral-Artery Stroke DESTINY II TRIAL Katherine Steele 7 April 2014.
Prediction and Prevention of Stroke in Patients with Symptomatic Carotid Stenosis: The High-risk Period and the High-risk Patient  P.M. Rothwell  European.
European Journal of Vascular and Endovascular Surgery
Table 1: Table 2: Non Therapeutic Angiograms in Acute Ischemic Stroke Patients Being Considered for Endovascular Treatment Does not Adversely Affect Patient.
Carotid Artery Stenosis
Critical Appraisal of the European CAS Trials
CQC Amit Gossain.
HOPE: Heart Outcomes Prevention Evaluation study
Cardiovascular Research Technology Conference (CRT 17)
Rabih A. Chaer MD Assistant Professor of Surgery
Quality of Referrals Guideline Congruence of referrals to TIAMS clinic
Selecting Patients Best Suited for CEA
Pooled Analysis of VA, ACAS, ACST-1 & GALA Trials
Risk of post-operative stroke in patients with known extra-cranial carotid artery disease undergoing Non-Cardiac Surgery Heart and Vascular.
PMA Analysis of the CREST Trial Approvability of the RX Acculink Carotid Stent System for Revascularization of Carotid Artery Stenosis in Standard Surgical.
Setareh Omran, MD Vascular Neurology Fellow
A presentation to: Meeting name Date
Differential outcomes of carotid stenting and endarterectomy performed exclusively by vascular surgeons in the Carotid Revascularization Endarterectomy.
Status Update from ACST-2
Preoperative risk factors for carotid endarterectomy: defining the patient at high risk  Amy B Reed, MD, Peter Gaccione, MA, Michael Belkin, MD, Magruder.
Predictors of 30-day postoperative stroke or death after carotid endarterectomy using the 2012 carotid endarterectomy-targeted American College of Surgeons.
Transcarotid Artery Revascularization versus Transfemoral Carotid Artery Stenting for Treatment of Carotid Artery Stenosis Patric Liang, MD; Marc L.
Presentation transcript:

Symptomatic vs. Asymptomatic Carotid Endarterectomy Morag Patterson March 12th 2008

Content Overview of evidence for carotid endarterectomy in symptomatic and asymptomatic patients Compare clinically relevant data Points to consider

Sources Cochrane review Cina CS, Clase CM, Haynes RB. Carotid endarterectomy for symptomatic carotid stenosis. Cochrane Database of Systematic Reviews 1999, Issue 3. Art. No.: CD001081. DOI: 10.1002/14651858.CD001081.

Sources Cochrane review Chambers BR, Donnan GA. Carotid endarterectomy for asymptomatic carotid stenosis. Cochrane Database of Systematic Reviews 2005, Issue 4. Art. No.: CD001923. DOI: 10.1002/14651858.CD001923.pub2.

Sources Draft version of SIGN guideline Management of patients with stroke or TIA: assessment, investigation, immediate management and secondary prevention Draft version of NICE guideline Stroke: diagnosis and initial management of acute stroke and TIA

Modified Rankin Score 0 No symptoms at all 1 Significant disability despite symptoms; able to carry out all usual duties and activities 2 Slight disability; unable to carry out all previous activities, but able to look after own affairs without assistance 3 Moderate disability; requiring some help, but able to walk without assistance 4 Moderately severe disability; unable to walk without assistance and unable to attend to own bodily needs without assistance 5 Severe disability; bedridden, incontinent and requiring constant nursing care and attention 6 Dead

Symptomatic 3 trials included (~6000 patients) European Carotid Surgery Trial North American Symptomatic Carotid Endarterectomy Trial Veterans Affairs Cooperative Studies Program

Symptomatic Carotid stenosis and TIA/MS in the territory of that artery (6/12) Best medical therapy vs BMT + surgery Outcome of death or major disability from stroke (MRS ≥ 3)

Exclusion Criteria Patients at “highest risk” ECST - equipoise, uncertainty principle Severe co-morbidity Tandem lesion (above C2) Prior ipsilateral surgery

Results ECST NASCET RRR/I (95% CI) ARR/I (95% CI) NNT/H 82-99 70-99 (27-63) ARR 6.7% (3.2-10) NNT 15 (10-31) 70-81 50-69 RRR 27% (5-44) ARR 4.7% (0.8-8.7) 21 (11-125) <70 <50 RRI 20% 0-44 ARI 2.2% (0-4.4) NNH 45 (22-inf)

Perioperative Outcomes MI (1-2%) Wound infection (3%) Haematoma (5%) Reversible nerve injury (5-7%) RR disabling stroke or death 2.5 in first 30 days after randomisation

Asymptomatic 3 trials included (5223 patients) Veterans Affairs Cooperative Study Asymptomatic Carotid Atherosclerosis Study Asymptomatic Carotid Surgery Trial

Asymptomatic Asymptomatic carotid stenosis no history at all of cerebrovascular symptoms remote (more than six months) ipsilateral carotid territory symptoms prior symptoms in the vertebrobasilar circulation prior carotid territory symptoms or a history of CEA on the contra-lateral side

Asymptomatic Best medical therapy vs. BMT + surgery Primary outcome Perioperative stroke or death, or stroke of any territory or type during follow up

Asymptomatic Perioperative stroke (of any territory or type) or death (from any cause), including the interval from randomisation to surgery and 30 days after surgery. Perioperative stroke or death or ipsilateral carotid territory stroke of any pathological type during subsequent follow up. Any stroke or death during the perioperative period and subsequent follow up.

Results Outcome RRR (CI) ARR PSoD or ipsilateral carotid territory stroke of any type 29% (10-40) - PSoD or stroke of any territory or type 31% (17-43) 1% Any stroke or death 8% NS PSoD = perioperative stroke or death

Conclusions Symptomatic Asymptomatic RRR of 48% ARR of 6.7% (>70% stenosis) RRR of 30% ARR of 1% (>60% stenosis) Outcome measure in studies was death or major disability from stroke Outcome measure in studies was perioperative stroke or death or any subsequent stroke

Conclusions Symptomatic Asymptomatic Patients with >50% stenosis should be considered for surgery. (50-69% male/within 2/52) Studies underpowered to determine differences in degree of stenosis - data suggests less benefit with high grade stenosis Increasing age and male sex confers increased ability to benefit (esp in lesser degree of stenosis) RRR for men > for women (51%vs 4%) RRR for younger age group > older (50% vs 9%)

Conclusions Symptomatic Asymptomatic Surgically fit patients and surgeon with <6% peri-operative complication Surgically fit patients and surgeon with <3% peri-operative complication Contralateral occlusion confers higher operative risk but persistent benefit Contralateral occlusion erases small benefit of CEA Surgery ceases to be of value after 12 weeks (m) and 2 weeks (w) (>70%) ? ACST only 88% had CEA within 12/12

Points to Consider BMT moved on since early 90s - erase benefit in 50-69% stenosis group? Rothwell PM, Mehta Z, Howard SC, Gutnikov SA, Warlow CP. From subgroups to individuals: general principles and the example of carotid endartectomy. Lancet 2004; 365; 256-265. Peri-operative risk assessment